Horwacik, J.; Maligłówka, M.; Bułdak, Ł.; Okopień, B.
The Future of Liver-Targeted Protein Synthesis Inhibition: Current Treatments, Emerging Strategies, and Next-Generation Therapeutics. Livers 2026, 6, 25.
https://doi.org/10.3390/livers6020025
AMA Style
Horwacik J, Maligłówka M, Bułdak Ł, Okopień B.
The Future of Liver-Targeted Protein Synthesis Inhibition: Current Treatments, Emerging Strategies, and Next-Generation Therapeutics. Livers. 2026; 6(2):25.
https://doi.org/10.3390/livers6020025
Chicago/Turabian Style
Horwacik, Julia, Mateusz Maligłówka, Łukasz Bułdak, and Bogusław Okopień.
2026. "The Future of Liver-Targeted Protein Synthesis Inhibition: Current Treatments, Emerging Strategies, and Next-Generation Therapeutics" Livers 6, no. 2: 25.
https://doi.org/10.3390/livers6020025
APA Style
Horwacik, J., Maligłówka, M., Bułdak, Ł., & Okopień, B.
(2026). The Future of Liver-Targeted Protein Synthesis Inhibition: Current Treatments, Emerging Strategies, and Next-Generation Therapeutics. Livers, 6(2), 25.
https://doi.org/10.3390/livers6020025